Literature DB >> 11174046

Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan.

A Kagaya1, A Kugaya, M Takebayashi, M Fukue-Saeki, T Saeki, S Yamawaki, Y Uchitomi.   

Abstract

There are a number of investigations which indicate the important relationship between depression and cytokines. In this study, we investigated plasma interleukin (IL)-1beta, IL-6, soluble IL-2 receptor (sIL-2R) and tumor necrosis factor (TNF)-alpha of depressed patients whose clinical evaluation was performed by the Hamilton Rating Scale for Depression (HAM-D) and the Profile of Mood States (POMS). They were compared with those of the control subjects, and before and after treatment with antidepressants. Before the treatment, plasma IL-1beta, IL-6, sIL-2R and TNF-alpha of the patients were not significantly different from those of the control subjects. sIL-2R was positively correlated with the POMS-tension-anxiety subscale and tended to have a positive correlation with HAM-D. After pharmacotherapy, TNF-alpha levels of the depressed patients increased, without any relationship between the change in the HAM-D or the POMS and the change in TNF-alpha. These results suggest that the plasma sIL-2R concentration is associated with mood state, and that the plasma TNF-alpha concentration is increased after pharmacotherapy in Japanese depressed patients. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11174046     DOI: 10.1159/000054867

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  21 in total

1.  The immune state of bulbectomized mice.

Authors:  E G Novoselova; N V Bobkova; O A Sinotova; V B Ogai; O V Glushkova; N I Medvinskaya; A N Samokhin
Journal:  Dokl Biol Sci       Date:  2003 Nov-Dec

Review 2.  The inflammation hypothesis in geriatric depression.

Authors:  George S Alexopoulos; Sarah Shizuko Morimoto
Journal:  Int J Geriatr Psychiatry       Date:  2011-03-02       Impact factor: 3.485

Review 3.  Inflammatory cytokine-associated depression.

Authors:  Francis E Lotrich
Journal:  Brain Res       Date:  2014-07-05       Impact factor: 3.252

4.  Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy.

Authors:  Gavin Rush; Aoife O'Donovan; Laura Nagle; Catherine Conway; AnnMaria McCrohan; Cliona O'Farrelly; James V Lucey; Kevin M Malone
Journal:  J Affect Disord       Date:  2016-06-17       Impact factor: 4.839

5.  A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Authors:  D R Goldsmith; M H Rapaport; B J Miller
Journal:  Mol Psychiatry       Date:  2016-02-23       Impact factor: 15.992

6.  Combined infliximab and methotrexate treatment improves the depressive state in rheumatoid arthritis patients more effectively than methotrexate alone.

Authors:  Yusuke Miwa; Airi Nishimi; Shinichiro Nishimi; Mayu Saito; Takahiro Tokunaga; Ryo Yanai; Ryo Takahashi; Kuninobu Wakabayashi; Tsuyoshi Kasama; Michio Hosaka
Journal:  Eur J Rheumatol       Date:  2014-12-01

7.  The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.

Authors:  Jonas Hannestad; Nicole DellaGioia; Michael Bloch
Journal:  Neuropsychopharmacology       Date:  2011-07-27       Impact factor: 7.853

8.  Impact of depression and its treatment on the bones of growing children.

Authors:  Elizabeth B Weller; Ronald A Weller; Angelica L Kloos; Stacie Hitchcock; Woo J Kim; Babette Zemel
Journal:  Curr Psychiatry Rep       Date:  2007-04       Impact factor: 5.285

9.  Relations of depressive symptoms and antidepressant use to body mass index and selected biomarkers for diabetes and cardiovascular disease.

Authors:  Yunsheng Ma; Raji Balasubramanian; Sherry L Pagoto; Kristin L Schneider; James R Hébert; Lawrence S Phillips; Joseph S Goveas; Annie L Culver; Barbara C Olendzki; James Beck; Jordan W Smoller; Deidre M Sepavich; Judith K Ockene; Lisa Uebelacker; Martha Zorn; Simin Liu
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

10.  Vortioxetine exerts anti-inflammatory and immunomodulatory effects on human monocytes/macrophages.

Authors:  Maria Talmon; Silvia Rossi; Anna Pastore; Carlo Ignazio Cattaneo; Sandra Brunelleschi; Luigia Grazia Fresu
Journal:  Br J Pharmacol       Date:  2017-11-28       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.